Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 97

1.

Reply to: A note on rotigotine for restless legs syndrome after renal transplantation.

Salminen AV, Allen RP, Högl B, Inoue Y, Oertel W, Winkelman JW, Trenkwalder C, Sampaio C, Winkelmann J.

Mov Disord. 2019 Jan;34(1):152-153. doi: 10.1002/mds.27570. No abstract available.

PMID:
30653726
2.

Reply to: Safety of dopamine agonists for treating restless legs syndrome.

Salminen AV, Allen RP, Högl B, Inoue Y, Oertel W, Winkelman JW, Trenkwalder C, Sampaio C, Winkelmann J.

Mov Disord. 2019 Jan;34(1):150-151. doi: 10.1002/mds.27571. No abstract available.

PMID:
30653723
3.

Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review.

Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Lloret SP, Weintraub D, Sampaio C; and the collaborators of the Parkinson's Disease Update on Non-Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence-Based Medicine Committee.

Mov Disord. 2019 Jan 17. doi: 10.1002/mds.27602. [Epub ahead of print] Review.

PMID:
30653247
4.

Cholecystokinin-2 Receptor Targeting with Novel C-terminally Stabilized HYNIC-Minigastrin Analogs Radiolabeled with Technetium-99m.

Klingler M, Rangger C, Summer D, Kaeopookum P, Decristoforo C, von Guggenberg E.

Pharmaceuticals (Basel). 2019 Jan 15;12(1). pii: E13. doi: 10.3390/ph12010013.

5.

Cerebrospinal Fluid Concentrations of the Synaptic Marker Neurogranin in Neuro-HIV and Other Neurological Disorders.

Yilmaz A, Fuchs D, Price RW, Spudich S, Blennow K, Zetterberg H, Gisslén M.

Curr HIV/AIDS Rep. 2019 Jan 16. doi: 10.1007/s11904-019-00420-1. [Epub ahead of print] Review.

PMID:
30649659
6.

High efficacy of rituximab for myasthenia gravis: a comprehensive nationwide study in Austria.

Topakian R, Zimprich F, Iglseder S, Embacher N, Guger M, Stieglbauer K, Langenscheidt D, Rath J, Quasthoff S, Simschitz P, Wanschitz J, Windisch D, Müller P, Oel D, Schustereder G, Einsiedler S, Eggers C, Löscher W.

J Neurol. 2019 Jan 16. doi: 10.1007/s00415-019-09191-6. [Epub ahead of print]

PMID:
30649616
7.

Estimating the epidemiology of anti-neutrophil cytoplasm antibody-associated renal vasculitis and the role of histologic chronicity in predicting renal outcomes.

Kronbichler A, Jayne DRW.

Nephrol Dial Transplant. 2019 Jan 14. doi: 10.1093/ndt/gfy402. [Epub ahead of print] No abstract available.

PMID:
30649435
8.

Heart failure due to cardiac myeloid sarcoma.

Tiller C, Reindl M, Klug G, Metzler B, Reinstadler SJ.

Eur Heart J Cardiovasc Imaging. 2019 Jan 10. doi: 10.1093/ehjci/jey226. [Epub ahead of print] No abstract available.

PMID:
30649243
9.

Cardiovascular Risk Factors Associated With Venous Thromboembolism.

Gregson J, Kaptoge S, Bolton T, Pennells L, Willeit P, Burgess S, Bell S, Sweeting M, Rimm EB, Kabrhel C, Zöller B, Assmann G, Gudnason V, Folsom AR, Arndt V, Fletcher A, Norman PE, Nordestgaard BG, Kitamura A, Mahmoodi BK, Whincup PH, Knuiman M, Salomaa V, Meisinger C, Koenig W, Kavousi M, Völzke H, Cooper JA, Ninomiya T, Casiglia E, Rodriguez B, Ben-Shlomo Y, Després JP, Simons L, Barrett-Connor E, Björkelund C, Notdurfter M, Kromhout D, Price J, Sutherland SE, Sundström J, Kauhanen J, Gallacher J, Beulens JWJ, Dankner R, Cooper C, Giampaoli S, Deen JF, Gómez de la Cámara A, Kuller LH, Rosengren A, Svensson PJ, Nagel D, Crespo CJ, Brenner H, Albertorio-Diaz JR, Atkins R, Brunner EJ, Shipley M, Njølstad I, Lawlor DA, van der Schouw YT, Selmer RM, Trevisan M, Verschuren WMM, Greenland P, Wassertheil-Smoller S, Lowe GDO, Wood AM, Butterworth AS, Thompson SG, Danesh J, Di Angelantonio E, Meade T; Emerging Risk Factors Collaboration.

JAMA Cardiol. 2019 Jan 16. doi: 10.1001/jamacardio.2018.4537. [Epub ahead of print]

PMID:
30649175
10.

Competing risks of major bleeding and thrombotic events with prasugrel-based dual antiplatelet therapy after stent implantation - An observational analysis from BASKET-PROVE II.

Jeger RV, Pfisterer M, Vogt DR, Galatius S, Abildgaard U, Naber C, Alber H, Eberli F, Kurz DJ, Pedrazzini G, Vuilliomenet A, Weilenmann D, Rickli H, Hansen KW, Rickenbacher P, Conen D, Müller C, Osswald S, Gilgen N, Kaiser C.

PLoS One. 2019 Jan 15;14(1):e0210821. doi: 10.1371/journal.pone.0210821. eCollection 2019.

11.

Immunosuppressives and biologics during pregnancy and lactation : A consensus report issued by the Austrian Societies of Gastroenterology and Hepatology and Rheumatology and Rehabilitation.

Puchner A, Gröchenig HP, Sautner J, Helmy-Bader Y, Juch H, Reinisch S, Högenauer C, Koch R, Hermann J, Studnicka-Benke A, Weger W, Puchner R, Dejaco C.

Wien Klin Wochenschr. 2019 Jan 14. doi: 10.1007/s00508-019-1448-y. [Epub ahead of print]

PMID:
30643992
12.

10 myths about frusemide.

Joannidis M, Klein SJ, Ostermann M.

Intensive Care Med. 2019 Jan 14. doi: 10.1007/s00134-018-5502-4. [Epub ahead of print] No abstract available.

PMID:
30643933
13.

Brain-Derived Neurotrophin and TrkB in Head and Neck Squamous Cell Carcinoma.

Dudás J, Riml A, Tuertscher R, Pritz C, Steinbichler TB, Schartinger VH, Sprung S, Glueckert R, Schrott-Fischer A, Johnson Chacko L, Riechelmann H.

Int J Mol Sci. 2019 Jan 11;20(2). pii: E272. doi: 10.3390/ijms20020272.

14.

Do Antimicrobial Proteins Contribute to Overcoming the Hidden Antifungal Crisis at the Dawn of a Post-Antibiotic Era?

Galgóczy L, Marx F.

Microorganisms. 2019 Jan 11;7(1). pii: E16. doi: 10.3390/microorganisms7010016.

15.

Immunotherapy in ovarian cancer: fake news or the real deal?

Marth C, Wieser V, Tsibulak I, Zeimet AG.

Int J Gynecol Cancer. 2019 Jan;29(1):201-211. doi: 10.1136/ijgc-2018-000011. Review.

PMID:
30640705
16.

Clinical pathways of recovery after surgery for advanced ovarian/tubal/peritoneal cancer: an NSGO-MaNGO international survey in collaboration with AGO-a focus on surgical aspects.

Piovano E, Ferrero A, Zola P, Marth C, Mirza MR, Lindemann K.

Int J Gynecol Cancer. 2019 Jan;29(1):181-187. doi: 10.1136/ijgc-2018-000021.

PMID:
30640702
17.

Correcting the R165K substitution in the first voltage-sensor of CaV1.1 right-shifts the voltage-dependence of skeletal muscle calcium channel activation.

El Ghaleb Y, Campiglio M, Flucher BE.

Channels (Austin). 2019 Jan 14. doi: 10.1080/19336950.2019.1568825. [Epub ahead of print]

PMID:
30638110
18.

Antifungal susceptibility of yeast blood stream isolates collected during a 10 year period in Austria.

Beyer R, Spettel K, Zeller I, Lass-Flörl C, Achleitner D, Krause R, Apfalter P, Buzina W, Strauss J, Gregori C, Schüller C, Willinger B.

Mycoses. 2019 Jan 12. doi: 10.1111/myc.12892. [Epub ahead of print]

PMID:
30636016
19.

Pomalidomide in primary intraocular lymphoma.

Bohn JP, Willenbacher W, Haas G, Peschel I, Oberacher H, Steurer M.

Leuk Lymphoma. 2019 Jan 11:1-3. doi: 10.1080/10428194.2018.1538508. [Epub ahead of print] No abstract available.

PMID:
30632826
20.

Ca2+-activated Cl- channel TMEM16A/ANO1 identified in zebrafish skeletal muscle is crucial for action potential acceleration.

Dayal A, Ng SFJ, Grabner M.

Nat Commun. 2019 Jan 10;10(1):115. doi: 10.1038/s41467-018-07918-z.

Supplemental Content

Loading ...
Support Center